CAL-101 (Idelalisib, GS-1101) is an oral PI3Kdelta-specific inhibitor that has shown preclinical and clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Molecular Weight:
415.42
Purity:
>99.0%
CAS Number:
[870281-82-6]
Formula:
C22H18FN7O
Target:
PI3K
* VAT and and shipping costs not included. Errors and price changes excepted